In a study of CAFs in NSCLC patients, CAFs with high expression of both HGF and FGF7, and CAFs with high expression of FGF7 were found to be differentially protective against tumors, and were associated with the immune microenvironment of tumors [92]. Here, FGF7 is linked to non-small cell lung carcinoma.